Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486146 · ClinicalTrials.gov registry record
GI Biorepository of Tissue and Bodily Fluids
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 789
- Enrollment target
NCT02486146: Completed study, sponsored by University of California, Davis.
NCT02486146 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 789 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02486146 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 789 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the working protocols for a general biorepository with the specific aim of procuring tissues and bodily fluids from the human gastrointestinal tract from a diverse range of clinical patients at the UC Davis Medical Center. The establishment of a GI-specific biorepository will support future translational endeavors within the UC Davis campus by providing laboratories with readily available GI tissue and bodily fluid samples to test newly developed hypotheses with relative ease.
Primary Outcome
To have biospecimens available for the UC Davis IRB approved studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 789 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-04 |
What the finished NCT02486146 record still lists
NCT02486146 is an observational study that tracks outcomes without assigning an intervention. The registered 789 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02486146 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02486146 about?
NCT02486146 is a clinical study titled "GI Biorepository of Tissue and Bodily Fluids". The purpose of this study is to establish the working protocols for a general biorepository with the specific aim of procuring tissues and bodily fluids from the human gastrointestinal tract from a diverse range of clinical patients at the UC Davis Medical Center. The establishment of a GI-specific ...
What is the current status of trial NCT02486146?
This trial is currently completed. The enrollment target is 789 participants. The study started on 2014-10. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT02486146?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04967989 · 790 participants · Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
- NCT06162611 · 790 participants · Phase 4
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
- NCT06488781 · 787 participants · Phase 2
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
- NCT06876649 · 787 participants · Phase 4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia